Streetbeat News

Analyst Ratings

SMCI

Whales are showing a bullish stance on Super Micro Computer (NASDAQ:SMCI) with significant options trading activity. 42% of trades are bullish, and 38% are bearish, with a total of $1,125,526 in call options and $1,090,704 in put options. Analysts have mixed ratings, with price targets ranging from $375 to $693.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:46 pm

JPM

Deep-pocketed investors are showing a bearish sentiment towards JPMorgan Chase, as revealed by Benzinga's options scanner. The options activity is unusual, with 24 significant trades detected, including 20 puts and 4 calls. The stock is currently down 5.14% at $205.68, with a neutral RSI. Analysts have set an average target price of $235, with Deutsche Bank downgrading to Hold.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:45 pm

CMPS

RBC Capital has reiterated its Outperform rating for Compass Pathways (NASDAQ:CMPS) and maintained a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:43 pm

SQSP

Barclays analyst Trevor Young maintains an Equal-Weight rating on Squarespace (NYSE:SQSP) and raises the price target from $44 to $47.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:42 pm

PSA

RBC Capital has initiated coverage on Public Storage (NYSE:PSA) with a Sector Perform rating and set a price target of $358.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:40 pm

CNSP

CNS Pharmaceuticals (CNSP) shares are trading higher following an upgrade from Maxim Group, which changed its rating from Hold to Buy and set a price target of $0.50.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:38 pm

RLAY

Barclays analyst Peter Lawson maintains an Overweight rating on Relay Therapeutics and raises the price target from $14 to $17.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:37 pm

ORCL

Barclays analyst Raimo Lenschow has maintained an Overweight rating on Oracle and increased the price target from $160 to $172.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:35 pm

AAPL

Piper Sandler analyst Matt Farrell has reiterated a Neutral rating on Apple (NASDAQ:AAPL) and maintained a price target of $225.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:35 pm

OSCR

Piper Sandler analyst Jessica Tassan has reiterated an Overweight rating on Oscar Health (NYSE:OSCR) and maintained a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:34 pm